Translational immunology
Bridge core immunology with clinical innovation, using multi-omics and patient data to accelerate precision immunotherapy and diagnostics.
In this intensive summer course, you will bridge fundamental immunology and clinical innovation, exploring how immune dysregulation, whether deficient, excessive, or chronically inflamed, drives infections, cancer, autoimmunity, and age-related diseases. You will examine breakthrough immunotherapies and learn to leverage multi-omics technologies and patient data to accelerate precision medicine, bridging from the bench to bedside. The course features world-renowned experts who will help you develop the skills to translate immune insights into next-generation diagnostics and therapeutics.
-
20 July – 24 July 2026
-
University of Hong Kong
-
HK$3,000 (Includes accommodation)
-
Apply by 31 May 2026
What you'll study
- Mechanisms of immune dysregulation
- Landmark immunotherapies
- Strategies pathogens and tumours use to subvert immune surveillance
- Integration of multi-omics data with clinical databases
- Principles of bench-to-bedside translation
- Emerging frontiers in personalised immunotherapy and immune-based diagnostics
If you have any enquiries about the course, please contact Gladys Chu by email at gladys@talent-links.com.
Course directors
Philip Li
Clinical Associate Professor, HKUMed, University of Hong Kong
Tak Wah Mak
Director, Advanced Medical Discovery Institute
Chak Sing Lau
Dean of Medicine, HKUMed, University of Hong Kong
Stay in the loop!
Subscribe to keep up with the latest from Croucher Foundation.